ctrl K

Watchlist Price Alert

Idera Pharmaceuticals Inc... (IDRA)

NASDAQ: IDRA · Real-Time Price · USD

0.42

-0.13 (-23.94%)

At close: Jan 17, 2023, 9:00 PM

Idera Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	1.45M	662K	902K	16.2M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	1.45M	662K	902K	16.2M
Operating Income	-29.47M	98.1M	-36.69M	-46.07M	-60.96M	-66.47M	-38.76M
Interest Income	n/a	9K	165K	1.15M	1.09M	574K	415K
Pretax Income	-29.68M	98.09M	-112.66M	-56.52M	-59.88M	-65.98M	-38.39M
Net Income	-23.36M	98.08M	-112.66M	-56.52M	-59.88M	-65.98M	-38.39M
Selling & General & Admin	12.21M	9.98M	11.91M	12.48M	15.42M	16.72M	15.13M
Research & Development	12.19M	16.38M	24.77M	34.85M	41.84M	50.65M	39.82M
Other Expenses	8.28M	1.32M	n/a	181K	4.36M	n/a	n/a
Operating Expenses	32.68M	27.67M	36.69M	47.33M	57.26M	67.37M	54.96M
Interest Expense	204K	7K	3K	n/a	11K	50K	80K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	32.68M	27.67M	36.69M	47.33M	57.26M	67.37M	54.96M
Income Tax Expense	-6.32M	7K	-75.97M	-10.45M	1.09M	533K	448K
Shares Outstanding (Basic)	3.26M	1.99M	1.99M	1.68M	1.56M	1.16M	938.21K
Shares Outstanding (Diluted)	3.26M	1.99M	1.99M	1.68M	1.56M	1.16M	938.21K
EPS (Basic)	-7.18	49.30	-56.63	-33.66	-38.27	-57.01	-40.92
EPS (Diluted)	-7.18	49.30	-56.63	-33.66	-38.27	-57.01	-40.92
EBITDA	-27.82M	98.12M	-112.6M	-56.4M	-59.44M	-65.19M	-37.65M
EBIT	-29.47M	98.1M	-112.66M	n/a	-59.87M	-65.93M	-38.31M
Depreciation & Amortization	1.66M	22K	61K	120K	432K	746K	656K